🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: fluticasone 100mcg Dry Powder Inhaler

Found 13 matching trials

Pharmacokinetic Profile of Four Formulations of Fluticasone Furoate (FF) Using Unit Dose Dry Powder Inhaler (UD-DPI) Compared With FF ELLIPTA® Presentation

PHASE1

This is an open-label, five- period, cross-over, randomized, single dose, s...

Status

Completed

Location

GSK Investigational Site

Start Date

2014-10-28

Trial ID

NCT02218723

Treatments Being Tested

FF UD-DPI FF ELLIPTA DPI

The Efficacy of Fluticasone Furoate/Vilanterol Versus (vs) Fluticasone Furoate on Asthma

PHASE4

The objective of this study is to evaluate fluticasone furoate/vilanterol c...

Status

Withdrawn

Location

Multiple Locations

Start Date

2018-03-07

Trial ID

NCT03363191

Treatments Being Tested

Fluticasone Furoate/Vilanterol Fluticasone Furoate Salbutamol/Albuterol

Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2

PHASE3

After screening, subjects will enter a 4 week open-label run-in period with...

Status

Completed

Location

GSK Investigational Site

Start Date

2013-10

Trial ID

NCT02119286

Treatments Being Tested

FF VI UMEC Placebo

Use of Mobile Devices and the Internet to Streamline an Asthma Clinical Trial

PHASE4

Asthma is an inflammatory disease that imposes a significant burden affecti...

Status

Completed

Location

Alfred I. duPont Hospital for Children

Start Date

2013-10

Trial ID

NCT02061280

Treatments Being Tested

fluticasone/salmeterol 250/50 Dry Powder Inhaler fluticasone/salmeterol 100/50 Dry Powder Inhaler fluticasone 100mcg Dry Powder Inhaler

Evaluation Inhaled Corticosteroids on Exhaled Nitric Oxide Gas Exchange

N/A

To evaluate the role of inhaled corticosteroids to suppress nitric oxide ga...

Status

Completed

Location

Arthur F Gelb MD

Start Date

2006-01

Trial ID

NCT00568347

Treatments Being Tested

fluticasone 100mcg/ salmeterol 50mcg fluticasone 250/salmeterol 50 salmeterol Salmeterol salmeterol and fluticasone propionate

Corrected QT (QTc) Study With Flucticasone Furoate and GW642444

PHASE1

A randomised, placebo controlled thorough QTc study to evaluate the effect ...

Status

Completed

Location

GSK Investigational Site

Start Date

2010-06-23

Trial ID

NCT01209026

Treatments Being Tested

Fluticasone furoate (200 mcg)/GW642444 (25mcg) combination Fluticasone furoate (400 mcg)/GW642444 (50mcg) combination Placebo Inhaler Moxifloxacin 400mg Moxifloxacin placebo

Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease

PHASE3

The purpose of this study is to determine if fluticasone furoate/vilanterol...

Status

Completed

Location

GSK Investigational Site

Start Date

2011-01-25

Trial ID

NCT01313676

Treatments Being Tested

fluticasone furoate/vilanterol fluticasone furoate vilanterol Placebo

A Comparison Study Between the Fixed Dose Triple Combination of Fluticasone Furoate/ Umeclidinium/ Vilanterol Trifenatate (FF/UMEC/VI) With Budesonide/Formoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

PHASE3

This is a phase IIIa, randomised, double-blind, double-dummy, parallel grou...

Status

Completed

Location

GSK Investigational Site

Start Date

2015-01-23

Trial ID

NCT02345161

Treatments Being Tested

Triple FF/UMEC/VI Placebo to match FF/UMEC/VI Budesonide/Formoterol Placebo to match Budesonide/Formoterol combination Albuterol/salbutamol

Inhaled Fluticasone Furoate/Vilanterol Safety and Tolerability, PK and PD Study

PHASE2

This study will investigate the safety and tolerability, pharmacokinetics, ...

Status

Completed

Location

GSK Investigational Site

Start Date

2011-10

Trial ID

NCT01453023

Treatments Being Tested

Fluticasone Furoate Fluticasone Furoate/Vilanterol

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

PHASE2

This is a Phase IIb, multi-centre, randomised, double-blind, parallel-group...

Status

Completed

Location

GSK Investigational Site

Start Date

2012-04

Trial ID

NCT01573767

Treatments Being Tested

Fluticasone propionate 100mcg Placebo Vilanterol

Previous Next